BCYC · Bicycle Therapeutics Plc ADR
United States · RS rating 15 · As of 2026-10-14
| Price | 3.51 USD |
|---|---|
| 1-day change | -3.3% |
| RS rating (overall / 1M / 3M / 12M) | 15 / 40 / 23 / 12 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 33 / 13 / 49 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +65.9% |
| Sales growth Q/Q | +308.7% |
| Distance from 52-week high | +59.9% |
| Market cap (USD) | $338.6M |